Peková Sona, Marková Jana, Pajer Petr, Dvorák Michal, Cetkovský Petr, Schwarz Jirí
Institute of Hematology and Blood Transfusion, Prague, Czech RepublicInstitute of Molecular Genetics, Academy of Sciences of the Czech Republic, Prague, Czech Republic.
Mol Diagn. 2005;9(1):23-34. doi: 10.2165/00066982-200509010-00004.
Patients with chronic lymphocytic leukemia (CLL) can relapse even after aggressive therapy and autografts. It is commonly assumed that to prevent relapse the level of minimal residual disease (MRD) should be as low as possible. To evaluate MRD, highly sensitive quantitative assays are needed.
The aim of the study was to develop a robust and sensitive method for detection of the clonal immunoglobulin heavy-chain variable (IgV(H)) rearrangement in CLL and to introduce a highly sensitive and specific methodology for MRD monitoring in patients with CLL who undergo intensive treatment.
As a prerequisite for MRD detection, touch-down reverse transcriptase (RT)-PCR using degenerate primers were used for the diagnostic identification of (H) gene rearrangement(s). For quantitative MRD detection in 18 patients, we employed a real-time RT-PCR assay (RQ-PCR) making use of patient-specific primers and the cost-saving Sybr-Green reporter dye (SG). For precise calibration of RQ-PCR, patient-specific IgV(H) sequences were cloned.
Touch-down RT-PCR with degenerate primers allowed the successful detection of IgV(H) clonal rearrangement(s) in 252 of 257 (98.1%) diagnostic samples. Biallelic rearrangements were found in 27 of 252 (10.7%) cases. Degenerate primers used for the identification of clonal expansion at diagnosis were not sensitive enough for MRD detection. In contrast, our RQ-PCR assay using patient-specific primers and SG reached the sensitivity of 10(-)(6). We demonstrated MRD in each patient tested, including four of four patients in complete remission following autologous hematopoietic stem cell transplantation (HSCT) and three of three following allogeneic 'mini'-HSCT. Increments in MRD might herald relapse; aggressive chemotherapy could induce molecular remission.
Our touch-down RT-PCR has higher efficiency to detect clonal IgV(H) rearrangements including the biallelic ones. MRD quantitation of IgV(H) expression using SG-based RQ-PCR represents a highly specific, sensitive, and economic alternative to the current quantitative methods.
慢性淋巴细胞白血病(CLL)患者即使经过积极治疗和自体移植后仍可能复发。通常认为,为预防复发,微小残留病(MRD)水平应尽可能低。为评估MRD,需要高度敏感的定量检测方法。
本研究的目的是开发一种可靠且敏感的方法,用于检测CLL中克隆性免疫球蛋白重链可变区(IgV(H))重排,并引入一种高度敏感和特异的方法,用于对接受强化治疗的CLL患者进行MRD监测。
作为MRD检测的前提条件,使用简并引物的降落式逆转录酶(RT)-PCR用于(H)基因重排的诊断性鉴定。对于18例患者的定量MRD检测,我们采用了实时RT-PCR检测法(RQ-PCR),使用患者特异性引物和成本较低的SYBR Green报告染料(SG)。为了对RQ-PCR进行精确校准,克隆了患者特异性IgV(H)序列。
使用简并引物的降落式RT-PCR成功检测到257份诊断样本中的252份(98.1%)存在IgV(H)克隆性重排。在252例病例中的27例(10.7%)发现了双等位基因重排。用于诊断时克隆性扩增鉴定的简并引物对MRD检测不够敏感。相比之下,我们使用患者特异性引物和SG的RQ-PCR检测法达到了10^(-)(6)的灵敏度。我们在每个检测的患者中都检测到了MRD,包括自体造血干细胞移植(HSCT)后完全缓解的4例患者中的4例,以及异基因“微型”HSCT后的3例患者中的3例。MRD的增加可能预示着复发;积极的化疗可诱导分子缓解。
我们的降落式RT-PCR在检测包括双等位基因重排在内的克隆性IgV(H)重排方面具有更高效率。使用基于SG的RQ-PCR对IgV(H)表达进行MRD定量,是目前定量方法的一种高度特异、敏感且经济的替代方法。